Financial results

Net profit of the Human Stem Cells Institute according to IFRS for 6 months of 2020 was ₽92,272 million, an increase of 46.8% as compared to ₽62,837 million in the previous year. Revenue increased 17.7% to ₽453.153 million, compared to ₽384.956 million a year earlier.